KKR to acquire Biosynth Carbosynth from Amira

KKR is funding its investment through the firm’s Health Care Strategic Growth strategy.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this